 |
encapsulated spores from fecal microbiota |
|---|---|
| Trade Name | |
| Orphan Indication | Recurrent Clostridium difficile infection (CDI) |
| USA Market Approval | USA |
| USA Designation Date | 2015-08-19 00:00:00 |
| Sponsor | Seres Therapeutics, Inc.;200 Sidney Street;Cambridge, Massachusetts, 02139 |
